RXMD's fundamentals are solid. The only thing standing between it and 7-10 cents per share is exposure. The price is holding steady even as volume increases, because buyers know they're buying into a once-in-a-lifetime opportunity.
Please note: CAPS, BOLD, & DOUBLE-BOLD text are no substitute for facts, & fancy COLORS are no replacement for logic & a convincing argument.